Increasing preference for dialysis over kidney replacement, technological advancements, and rising
geriatric population are a few factors driving the global kidney dialysis equipment market. However, the
high cost of dialysis, associated complications, and lack of reimbursement are a few factors restraining
the global kidney dialysis equipment market.
Improved hospital infrastructure in developed regions such as North America and Europe, rising
investments by key players in Asia Pacific are key factors that are projected to drive the market during
the forecast period.
Kidney Dialysis Equipment Market Covers the Table of Contents With Segments, Key Players And Region.
Based on Product Type, Kidney Dialysis Equipment Market is sub segmented into Hemodialysis (HD)
Equipment and Peritoneal Dialysis (PD) Equipment. On the Basis of Application, Market is sub
segmented into In-Center Dialysis Settings and Home Care Settings.
Major Players profiled in the Kidney Dialysis Equipment Market report incorporate: Fresenius Medical
Care (KGaA Fresenius), Baxter International, Nipro, B. Braun Melsungen, Nikkiso, NxStage Medical
Top Industry for Kidney Dialysis Equipment Market News
1 Fresenius Medical Care
Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced
the launch of its 4008A dialysis machine, which was especially designed to meet the needs of emerging
markets. With the launch of the 4008A, the company is aiming to improve accessibility to life-sustaining
dialysis treatment for patients in these countries who are living with end-stage renal disease (ESRD).
The 4008A dialysis machine incorporates Fresenius Medical Care’s high therapy standards while
minimizing costs for health care systems. It has primarily been deployed in India, with other countries
across the Asia-Pacific region to follow. Worldwide, there is an urgent and growing need for patients
with ESRD to receive access to dialysis. A systematic review of worldwide access to treatment estimated
that almost two million people in Asia with ESRD who needed dialysis were not receiving it – a
treatment gap that is double the number of patients actively being treated. Worldwide use of dialysis is
projected to more than double by 2030, with the most growth in Asia, but the number of people
without access to dialysis is expected to remain substantial
2 Baxter International
A global innovator in renal care, showcased 19 data presentations on therapy options at the 56th ERA-
EDTA Congress, Budapest, Hungary, June 13-16. The presentations spanned the renal care continuum,
from chronic kidney disease (CKD) management to peritoneal dialysis (PD) and hemodialysis (HD). This
included five independent studies conducted on HDx (expanded hemodialysis) that further advance
growing evidence for the therapy.
Request a Discount on standard prices of this premium report @
https://www.businessindustryreports.com/check-discount/167380 .